New eye implant shows promise for Long-Term wet AMD control
NCT ID NCT07516132
First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 3 times
Summary
This study is checking the long-term safety of an implant called OTX-TKI (axitinib) for people with wet age-related macular degeneration (AMD). The implant is placed in the eye and slowly releases medicine to control the disease. About 850 people who already completed two years of treatment in earlier studies will be followed for up to three more years. The main goal is to see if the implant remains safe over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- axitinib implant (OTX-TKI)
- What this could lead to
- If successful, this could show that the axitinib implant is safe for long-term use, potentially offering a treatment that reduces the need for frequent eye injections for wet AMD.
- What could go wrong
- This is an extension study focused on safety, not on how well the treatment works. It only includes people who already did well in earlier trials, so results may not apply to everyone with wet AMD.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Austin Retina Associates
RECRUITINGAustin, Texas, 78705, United States
-
California Retina Consultants (CRC)
RECRUITINGBakersfield, California, 93309, United States
-
California Retina Consultants (CRC)
RECRUITINGSanta Barbara, California, 93103, United States
-
Cumberland Valley Retina Associates
RECRUITINGHagerstown, Maryland, 21740, United States
-
Mid Atlantic Retina Specialists
RECRUITINGHagerstown, Maryland, 21740, United States
-
Palmetto Retina Center
RECRUITINGWest Columbia, South Carolina, 29619, United States
-
Retina Group of Florida - Fort Lauderdale
RECRUITINGFort Lauderdale, Florida, 33308, United States
-
Retina Group of New England
RECRUITINGWaterford, Connecticut, 06385, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Time gene therapy tame wet AMD for years?
- Laser zap before eye injection could cut needle count for wet AMD
- New eye injection shows promise for wet AMD in everyday practice
- New syringe could simplify High-Dose eye treatment
- New eye drug faricimab tested for blinding disease
- New eye drug trial aims for safer wet AMD treatment